Latest North America News

INOVIQ Limited reported a $6.9 million net loss for FY25 while making significant strides in its exosome-based cancer diagnostics and therapeutics pipeline, including a breakthrough ovarian cancer screening test and promising CAR-exosome therapy results.

NOVONIX Limited reports progress scaling its Chattanooga synthetic graphite plant, secures major funding, and benefits from U.S. tariffs on Chinese imports, while narrowing its half-year loss.

CLINUVEL Pharmaceuticals is preparing to elevate its American Depository Receipt program to a Nasdaq Level II listing by the end of 2025, aiming to enhance visibility and trading access in the U.S. without altering its primary ASX listing.

EOS has reported a 126% increase in its contract backlog to $307 million in 1H 2025, driven by strong demand for its defence and space technologies despite a revenue decline. The company secured a landmark €71.4 million high energy laser weapon export contract and continues to strengthen its balance sheet.

Australian Vintage Limited reported a strong FY25 with significant profit growth despite flat revenue, underpinned by innovation and cost-cutting initiatives. The company aims for positive free cash flow in FY26, propelled by global brand expansion and operational efficiencies.

Australian Vintage reported a slight sales dip in FY25 but improved earnings and cash flow, setting the stage for a transformational FY26 driven by innovative brands and strategic expansion.

Codan Limited reported a robust FY25 with 22% revenue growth to $674.2 million and a 27% jump in net profit, driven by organic expansion and strategic acquisitions. The company’s communications and metal detection segments both posted solid gains, setting a confident tone for FY26.

Redox Ltd reported a robust 9.4% increase in revenue for FY25, supported by strong volume growth and three strategic acquisitions, despite margin compression and a challenging macroeconomic backdrop.

Redox Limited reported a 9.4% increase in FY25 revenue to $1.244 billion amid challenging global conditions, while profit after tax declined 14.6% to $77.1 million due to margin normalization and rising costs. The company completed three strategic acquisitions and declared a fully franked dividend of 12.5 cents per share.

Goodman Group reported a robust FY25 with a 13% rise in operating profit to $2.31 billion, driven by strong data centre development and strategic capital management. The Group targets continued growth with a 9% OEPS increase forecast for FY26.

Brambles Limited reported a robust 10% increase in underlying profit for FY25, driven by sales growth and asset efficiency, while announcing a US$400 million share buy-back for FY26. The company also outlined a positive outlook with continued digital transformation and sustainability progress.

Brambles Limited reported a 10% rise in underlying profit for FY25, driven by operational efficiencies and digital initiatives, while announcing a US$400 million share buy-back for FY26. The company’s transformation program underpins a confident outlook despite macroeconomic headwinds.